NO995267L - Leptin som en inhibitor av tumorcelleproliferering - Google Patents

Leptin som en inhibitor av tumorcelleproliferering

Info

Publication number: NO995267L
Authority: NO; Norway
Prior art keywords: leptin; inhibitor; cell proliferation; tumor cell; tumor
Prior art date: 1997-04-29

Application number

NO995267A

Other languages

English (en)

Other versions

NO995267D0 (no

NO322304B1 (no

Inventor

Dalit Barkan

Batya Cohen

Menachem Rubinstein

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-29

Filing date

1999-10-28

Publication date

1999-12-28

1999-10-28 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

1999-10-28 Publication of NO995267D0 publication Critical patent/NO995267D0/no

1999-12-28 Publication of NO995267L publication Critical patent/NO995267L/no

2006-09-11 Publication of NO322304B1 publication Critical patent/NO322304B1/no

Links

102000016267 Leptin Human genes 0.000 title 1
108010092277 Leptin Proteins 0.000 title 1
230000004663 cell proliferation Effects 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
229940039781 leptin Drugs 0.000 title 1
210000004881 tumor cell Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19995267A 1997-04-29 1999-10-28 Anvendelse av leptin for fremstilling av et medikament for inhibering av human brystkarcinomcelleproliferering NO322304B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL12073397A IL120733A0 (en)	1997-04-29	1997-04-29	Leptin as an inhibitor of cell proliferation
PCT/IL1998/000196 WO1998048831A1 (en)	1997-04-29	1998-04-26	Leptin as an inhibitor of tumor cell proliferation

Publications (3)

Publication Number	Publication Date
NO995267D0 NO995267D0 (no)	1999-10-28
NO995267L true NO995267L (no)	1999-12-28
NO322304B1 NO322304B1 (no)	2006-09-11

Family

ID=11070075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19995267A NO322304B1 (no)	1997-04-29	1999-10-28	Anvendelse av leptin for fremstilling av et medikament for inhibering av human brystkarcinomcelleproliferering

Country Status (25)

Country	Link
US (1)	US7109159B1 (no)
EP (1)	EP0981365B1 (no)
JP (1)	JP4330662B2 (no)
KR (1)	KR100507731B1 (no)
CN (1)	CN1168497C (no)
AR (1)	AR012626A1 (no)
AT (1)	ATE283702T1 (no)
AU (1)	AU742927B2 (no)
BG (1)	BG63490B1 (no)
CA (1)	CA2288238A1 (no)
CZ (1)	CZ299872B6 (no)
DE (1)	DE69827942T2 (no)
EA (1)	EA002353B1 (no)
EE (1)	EE04801B1 (no)
ES (1)	ES2232944T3 (no)
HU (1)	HUP0002427A3 (no)
IL (2)	IL120733A0 (no)
NO (1)	NO322304B1 (no)
NZ (1)	NZ500589A (no)
PL (1)	PL195275B1 (no)
PT (1)	PT981365E (no)
SK (1)	SK284848B6 (no)
UA (1)	UA66793C2 (no)
WO (1)	WO1998048831A1 (no)
ZA (1)	ZA983608B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7208572B2 (en)	1998-08-21	2007-04-24	Albany Medical College	Leptin-related peptides
US6777388B1 (en)	1998-08-21	2004-08-17	Clf Medical Technology Acceleration Program, Inc.	Leptin-related peptides
US20050272652A1 (en)	1999-03-29	2005-12-08	Gault Victor A	Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) *	1999-09-05	2001-03-19	Yeda Res & Dev	Use of leptin in inhibition of endothelial cell proliferation
US8076288B2 (en)	2004-02-11	2011-12-13	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides having glucose lowering activity
NZ579621A (en)	2004-02-11	2011-03-31	Amylin Pharmaceuticals Inc	Hybrid polypeptides with selectable properties
US7863240B2 (en) *	2004-10-08	2011-01-04	Enzo Therapeutics, Inc.	Methods and uses of leptin in hepatocellular carcinoma
US8969291B2 (en)	2004-10-08	2015-03-03	Enzo Therapeutics, Inc.	Methods for decreasing leptin levels or activity for treating inflammation
KR20070115947A (ko)	2005-02-11	2007-12-06	아밀린 파마슈티칼스, 인크.	선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드
WO2007022123A2 (en)	2005-08-11	2007-02-22	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
US8263545B2 (en)	2005-02-11	2012-09-11	Amylin Pharmaceuticals, Inc.	GIP analog and hybrid polypeptides with selectable properties
EP2330125A3 (en)	2005-08-11	2012-12-12	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
US8716220B2 (en) *	2005-09-07	2014-05-06	Nikolaos Tezapsidis	Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
US8227408B2 (en) *	2005-09-07	2012-07-24	Neurotez, Inc.	Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8497240B2 (en)	2006-08-17	2013-07-30	Amylin Pharmaceuticals, Llc	DPP-IV resistant GIP hybrid polypeptides with selectable properties
MX344166B (es) *	2008-02-08	2016-12-07	Ambrx Inc	Leptina-polipeptidos modificados y sus usos.
CA2725143A1 (en) *	2008-05-21	2009-11-26	Neurotez, Inc.	Methods for treating progressive cognitive disorders related to neurofibrillary tangles
US20100316639A1 (en)	2009-06-16	2010-12-16	Genentech, Inc.	Biomarkers for igf-1r inhibitor therapy
TW202417497A (zh)	2015-10-12	2024-05-01	美商再生元醫藥公司	活化瘦素受體的抗原結合蛋白
LT3538554T (lt)	2016-11-08	2025-10-10		Antigeną surišantys baltymai, antagonizuojantys leptino receptorius
SG11202005146VA (en)	2017-12-18	2020-06-29	Regeneron Pharma	Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
PT3773713T (pt)	2018-04-06	2025-07-29	Regeneron Pharma	Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia
CN120629571B (zh) *	2025-06-13	2026-03-27	蚌埠医学院第一附属医院（蚌埠医学院附属肿瘤医院）	Lepr基因或蛋白作为靶标在制备胆管细胞癌治疗产品中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP9802609A2 (hu) *	1995-06-30	1999-03-29	Eli Lilly And Co.	A diabetes kezelésére szolgáló eljárás
EP0764722A2 (en) *	1995-09-19	1997-03-26	Eli Lilly And Company	DNA encoding primate leptins as medicinal proteins
WO1997027286A1 (en) *	1996-01-23	1997-07-31	Progenitor, Inc.	Methods for using the obese gene and its gene product to stimulate hematopoietic development

1997
- 1997-04-29 IL IL12073397A patent/IL120733A0/xx unknown
1998
- 1998-04-26 ES ES98917580T patent/ES2232944T3/es not_active Expired - Lifetime
- 1998-04-26 EA EA199900981A patent/EA002353B1/ru not_active IP Right Cessation
- 1998-04-26 JP JP54678798A patent/JP4330662B2/ja not_active Expired - Fee Related
- 1998-04-26 KR KR10-1999-7009705A patent/KR100507731B1/ko not_active Expired - Fee Related
- 1998-04-26 HU HU0002427A patent/HUP0002427A3/hu unknown
- 1998-04-26 AT AT98917580T patent/ATE283702T1/de active
- 1998-04-26 CA CA002288238A patent/CA2288238A1/en not_active Abandoned
- 1998-04-26 CN CNB988066920A patent/CN1168497C/zh not_active Expired - Fee Related
- 1998-04-26 DE DE69827942T patent/DE69827942T2/de not_active Expired - Lifetime
- 1998-04-26 WO PCT/IL1998/000196 patent/WO1998048831A1/en not_active Ceased
- 1998-04-26 PT PT98917580T patent/PT981365E/pt unknown
- 1998-04-26 CZ CZ0384899A patent/CZ299872B6/cs not_active IP Right Cessation
- 1998-04-26 UA UA99116415A patent/UA66793C2/uk unknown
- 1998-04-26 NZ NZ500589A patent/NZ500589A/xx not_active IP Right Cessation
- 1998-04-26 US US09/403,897 patent/US7109159B1/en not_active Expired - Fee Related
- 1998-04-26 SK SK1471-99A patent/SK284848B6/sk not_active IP Right Cessation
- 1998-04-26 EP EP98917580A patent/EP0981365B1/en not_active Expired - Lifetime
- 1998-04-26 AU AU70762/98A patent/AU742927B2/en not_active Ceased
- 1998-04-26 EE EEP199900510A patent/EE04801B1/xx not_active IP Right Cessation
- 1998-04-26 PL PL98336582A patent/PL195275B1/pl not_active IP Right Cessation
- 1998-04-29 ZA ZA983608A patent/ZA983608B/xx unknown
- 1998-04-29 AR ARP980102003A patent/AR012626A1/es unknown
1999
- 1999-10-25 BG BG103832A patent/BG63490B1/bg unknown
- 1999-10-28 IL IL132633A patent/IL132633A/en not_active IP Right Cessation
- 1999-10-28 NO NO19995267A patent/NO322304B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO995267D0 (no)	1999-10-28
EE04801B1 (et)	2007-04-16
CA2288238A1 (en)	1998-11-05
CN1261802A (zh)	2000-08-02
UA66793C2 (uk)	2004-06-15
DE69827942T2 (de)	2005-12-08
SK284848B6 (sk)	2006-01-05
HUP0002427A2 (hu)	2000-12-28
PL336582A1 (en)	2000-07-03
ZA983608B (en)	1998-11-02
CZ384899A3 (cs)	2000-06-14
CN1168497C (zh)	2004-09-29
IL120733A0 (en)	1997-08-14
CZ299872B6 (cs)	2008-12-17
PT981365E (pt)	2005-03-31
WO1998048831A1 (en)	1998-11-05
PL195275B1 (pl)	2007-08-31
JP2001524968A (ja)	2001-12-04
BG63490B1 (bg)	2002-03-29
ATE283702T1 (de)	2004-12-15
AU742927B2 (en)	2002-01-17
JP4330662B2 (ja)	2009-09-16
EP0981365A1 (en)	2000-03-01
NO322304B1 (no)	2006-09-11
IL132633A (en)	2007-07-04
EA199900981A1 (ru)	2000-04-24
EE9900510A (et)	2000-06-15
DE69827942D1 (de)	2005-01-05
KR100507731B1 (ko)	2005-08-10
KR20010012080A (ko)	2001-02-15
AR012626A1 (es)	2000-11-08
HUP0002427A3 (en)	2003-02-28
SK147199A3 (en)	2000-06-12
EA002353B1 (ru)	2002-04-25
NZ500589A (en)	2001-03-30
BG103832A (en)	2000-10-31
AU7076298A (en)	1998-11-24
HK1028350A1 (en)	2001-02-16
ES2232944T3 (es)	2005-06-01
EP0981365B1 (en)	2004-12-01
US7109159B1 (en)	2006-09-19

Legal Events

Date	Code	Title	Description
2013-12-02	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO995267L (no)	1999-12-28	Leptin som en inhibitor av tumorcelleproliferering
DK1001934T3 (da)	2002-12-30	Indolforbindelser som COX-2-inhibitorer
FI962800L (fi)	1996-09-06	Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
ID20611A (id)	1999-01-28	Formulasi pelindung terhadap uv
DK1027332T3 (da)	2004-10-04	Hidtil ukendte lactametalloproteaseinhibitorer
CY2012029I2 (el)	2015-08-05	Nεα μορφη της 5-ομεπραζολης
DE69928195D1 (de)	2005-12-15	Komplettierung von Untrerdruck-Bohrlöchern
EE03685B1 (et)	2002-04-15	Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid
NO20000300D0 (no)	2000-01-21	Hydrogenolyse av glycerol
NO20004217D0 (no)	2000-08-23	Inhibitorer av fosfolipase A2
DK0958287T3 (da)	2003-01-20	Sulfamidmetalloprotease-inhibitorer
PT927183E (pt)	2004-12-31	Inibidores espirociclicos de metaloproteases
ID22650A (id)	1999-12-02	Penggunaan penghambat-penghambat lipase usus lambung
PT956294E (pt)	2004-10-29	Inibidores da trombina
PT1047450E (pt)	2003-02-28	Combinacoes inibidor ace - inibidor mmp
PT948483E (pt)	2002-08-30	Inibidores da farnesil-transferase
IT1298751B1 (it)	2000-02-02	Procedimento di inibizione della polimerizzazione
EE200100061A (et)	2002-06-17	Migreeni kordumise ärahoimine
IT240802Y1 (it)	2001-04-11	Struttura di dischetto levatrucco
ID28032A (id)	2001-05-03	TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
FI971909A0 (fi)	1997-05-05	Bearbetning av taetningsytan pao doerrposten foer en koksningsugn
NO20001200D0 (no)	2000-03-08	Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase
DE69828361D1 (de)	2005-02-03	Apoptose-inhibitor
DK0981365T3 (da)	2005-03-21	Leptin som en inhibitor af tumorcelleproliferation
ID22163A (id)	1999-02-11	Selongsong disk